Nutex Health (NUTX) Invested Capital (2010 - 2026)

Nutex Health has disclosed Invested Capital across 17 years of filings, most recently posting $458.8 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $458.8 million, up 76.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $458.8 million (up 76.48% YoY), and the FY2025 annual result was $656.2 million, up 239.93% from the prior year.
• Invested Capital came in at $458.8 million for Q1 2026 at Nutex Health, down from $656.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $656.2 million in Q4 2025 to a low of $82.7 million in Q4 2023.
• The 5-year median for Invested Capital is $158.7 million (2022), against an average of $244.1 million.
• Across the five-year window, Invested Capital plunged 78.22% in 2023 and soared 426.69% in 2025, its largest moves.
• Nutex Health's Invested Capital stood at $158.7 million in 2022, then slumped by 47.87% to $82.7 million in 2023, then soared by 133.4% to $193.0 million in 2024, then soared by 239.93% to $656.2 million in 2025, then sank by 30.08% to $458.8 million in 2026.
• The last three Invested Capital figures came in at $458.8 million (Q1 2026), $656.2 million (Q4 2025), and $442.8 million (Q3 2025), per Business Quant data.